Clinical Trial Update: Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports sustained benefit of atomoxetine hydrochloride in adolescents with Attention-Deficit/Hyperactivity Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED